Construction To Begin On Gulf Biotech's $93 Million Insulin Plant
This article was originally published in PharmAsia News
Executive Summary
Gulf Biotech, backed by global drug makers such as Merck, Helm and Linde, expects to begin construction soon on a $93 million insulin-production plant in Bahrain.